Argent Trust CO Biomarin Pharmaceutical Inc Transaction History

Argent Trust CO

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$74.73 - $90.69 $482,307 - $585,313	-6,454 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$72.61 - $90.2 $50,100 - $62,238	690 Added 11.97%	6,454 $566,000
Q3 2020 Nov 13, 2020	BUY	$71.87 - $131.03 $153,945 - $280,666	2,142 Added 59.14%	5,764 $438,000
Q2 2020 Aug 04, 2020	BUY	$79.55 - $124.22 $27,524 - $42,980	346 Added 10.56%	3,622 $447,000
Q1 2020 May 11, 2020	SELL	$71.37 - $96.85 $45,676 - $61,984	-640 Reduced 16.34%	3,276 $277,000
Q4 2019 Feb 11, 2020	SELL	$64.27 - $86.37 $62,020 - $83,347	-965 Reduced 19.77%	3,916 $331,000
Q3 2019 Nov 12, 2019	BUY	$67.4 - $85.11 $41,451 - $52,342	615 Added 14.42%	4,881 $329,000
Q2 2019 Aug 13, 2019	BUY	$80.35 - $93.9 $57,610 - $67,326	717 Added 20.2%	4,266 $365,000
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $43,447 - $50,887	516 Added 17.01%	3,549 $315,000
Q4 2018 Feb 06, 2019	SELL	$80.14 - $106.07 $52,091 - $68,945	-650 Reduced 17.65%	3,033 $258,000
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $3,568 - $4,017	-38 Reduced 1.02%	3,683 $357,000
Q2 2018 Apr 15, 2019	BUY	$76.01 - $99.03 $2,888 - $3,763	38 Added 1.03%	3,721 $349,000
Q2 2018 Aug 15, 2018	SELL	$76.01 - $99.03 $127,392 - $165,974	-1,676 Reduced 31.27%	3,683 $347,000
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $66,097 - $78,828	-851 Reduced 13.7%	5,359 $434,000
Q4 2017 Feb 12, 2018	BUY	$80.76 - $95.13 $21,643 - $25,494	268 Added 4.51%	6,210 $554,000
Q3 2017 Nov 13, 2017	BUY	$80.6 - $94.95 $478,925 - $564,192	5,942	5,942 $553,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

Stay updated on Argent Trust CO with notifications on news.